• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用外泌体的力量用于血液系统恶性肿瘤的诊断、预后评估和治疗。

Harnessing the power of exosomes for diagnosis, prognosis, and treatment of hematological malignancies.

作者信息

Mohseni Amirata, Salehi Fatemeh, Rostami Samaneh, Hadiloo Kaveh, Hashemi Mehrdad, Baridjavadi Zahra, Ahangari Fatemeh, Karami Najibeh, Samani Fatemeh, Tahmasebi Safa, Farahani Najma, Taheriazam Afshin

机构信息

Department of Molecular Medicine, University of Pavia, Pavia, Italy.

School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.

出版信息

Stem Cell Res Ther. 2025 Jan 7;16(1):6. doi: 10.1186/s13287-024-04125-0.

DOI:10.1186/s13287-024-04125-0
PMID:39773361
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11708188/
Abstract

Exosomes are small extracellular vesicles of endocytic origin released by various cell types. They consist of lipid bilayers containing macromolecules such as lipids, proteins, microRNAs, growth factors, cytokines, and carbohydrates. Exosomes play a critical role in the diagnosis and treatment of various diseases. For instance, exosome contents have been utilized as biomarkers in body fluids (urine, saliva, serum) to identify cancers, autoimmune diseases, and inflammatory conditions such as sepsis. Due to their small size and ability to reach tumor microenvironments, exosomes are also used as carriers for chemotherapeutic drugs in drug delivery systems. Furthermore, evidence indicates that malignant cells release exosomes into the tumor microenvironment, influencing immune cells in a paracrine manner. Additionally, immune cell-derived exosomes, such as those from Natural Killer (NK) cells or cytotoxic T lymphocytes (CTLs), show potential as therapeutic agents in treating malignancies like leukemia. This review discusses the diagnostic role of exosomes in various hematological malignancies and explores the therapeutic potential of immune cell-derived exosomes in these diseases.

摘要

外泌体是由多种细胞类型释放的内吞来源的小细胞外囊泡。它们由包含脂质、蛋白质、微小RNA、生长因子、细胞因子和碳水化合物等大分子的脂质双层组成。外泌体在各种疾病的诊断和治疗中发挥着关键作用。例如,外泌体内容物已被用作体液(尿液、唾液、血清)中的生物标志物,以识别癌症、自身免疫性疾病和炎症性疾病,如败血症。由于其体积小且能够到达肿瘤微环境,外泌体还被用作药物递送系统中化疗药物的载体。此外,有证据表明恶性细胞将外泌体释放到肿瘤微环境中,以旁分泌方式影响免疫细胞。此外,免疫细胞衍生的外泌体,如来自自然杀伤(NK)细胞或细胞毒性T淋巴细胞(CTL)的外泌体,在治疗白血病等恶性肿瘤方面显示出作为治疗剂的潜力。本文综述讨论了外泌体在各种血液系统恶性肿瘤中的诊断作用,并探讨了免疫细胞衍生的外泌体在这些疾病中的治疗潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e53c/11708188/811499e8690c/13287_2024_4125_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e53c/11708188/c3d66467166b/13287_2024_4125_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e53c/11708188/156b5a0bf447/13287_2024_4125_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e53c/11708188/811499e8690c/13287_2024_4125_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e53c/11708188/c3d66467166b/13287_2024_4125_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e53c/11708188/156b5a0bf447/13287_2024_4125_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e53c/11708188/811499e8690c/13287_2024_4125_Fig3_HTML.jpg

相似文献

1
Harnessing the power of exosomes for diagnosis, prognosis, and treatment of hematological malignancies.利用外泌体的力量用于血液系统恶性肿瘤的诊断、预后评估和治疗。
Stem Cell Res Ther. 2025 Jan 7;16(1):6. doi: 10.1186/s13287-024-04125-0.
2
Exosome-Mediated Therapeutic Strategies for Management of Solid and Hematological Malignancies.外泌体介导的实体瘤和血液系统恶性肿瘤治疗策略。
Cells. 2022 Mar 27;11(7):1128. doi: 10.3390/cells11071128.
3
Recent Progress of Exosomes in Hematological Malignancies: Pathogenesis, Diagnosis, and Therapeutic Strategies.外泌体在血液系统恶性肿瘤中的最新进展:发病机制、诊断和治疗策略。
Int J Nanomedicine. 2024 Nov 9;19:11611-11631. doi: 10.2147/IJN.S479697. eCollection 2024.
4
The emerging roles of tumor-derived exosomes in hematological malignancies.肿瘤衍生外泌体在血液系统恶性肿瘤中的新兴作用。
Leukemia. 2017 Jun;31(6):1259-1268. doi: 10.1038/leu.2017.91. Epub 2017 Mar 21.
5
Deciphering the messages carried by extracellular vesicles in hematological malignancies.解析血液恶性肿瘤细胞外囊泡所携带的信息。
Blood Rev. 2021 Mar;46:100734. doi: 10.1016/j.blre.2020.100734. Epub 2020 Jul 14.
6
Hematological Malignancy-Derived Small Extracellular Vesicles and Tumor Microenvironment: The Art of Turning Foes into Friends.血液系统恶性肿瘤衍生的小细胞外囊泡与肿瘤微环境:化敌为友的艺术。
Cells. 2019 May 27;8(5):511. doi: 10.3390/cells8050511.
7
Emerging role of exosomes in hematological malignancies.外泌体在血液系统恶性肿瘤中的新兴作用。
Clin Exp Med. 2023 Aug;23(4):1123-1136. doi: 10.1007/s10238-022-00850-z. Epub 2022 Jul 7.
8
Exosomes in tumor microenvironment: novel transporters and biomarkers.肿瘤微环境中的外泌体:新型转运体与生物标志物
J Transl Med. 2016 Oct 19;14(1):297. doi: 10.1186/s12967-016-1056-9.
9
Exosomal microRNA panels as biomarkers for hematological malignancies.外泌体 microRNA 谱作为血液系统恶性肿瘤的生物标志物。
Curr Probl Cancer. 2021 Oct;45(5):100726. doi: 10.1016/j.currproblcancer.2021.100726. Epub 2021 Mar 5.
10
Application of cell-derived exosomes in the hematological malignancies therapy.细胞来源外泌体在血液系统恶性肿瘤治疗中的应用。
Front Pharmacol. 2023 Sep 8;14:1263834. doi: 10.3389/fphar.2023.1263834. eCollection 2023.

引用本文的文献

1
Extracellular Vesicle Lipids and Their Role in Delivery.细胞外囊泡脂质及其在递送中的作用。
J Extracell Biol. 2025 Jun 23;4(6):e70064. doi: 10.1002/jex2.70064. eCollection 2025 Jun.

本文引用的文献

1
Global Trends of Exosomes Application in Clinical Trials: A Scoping Review.全球范围内外泌体在临床试验中的应用趋势:范围综述。
Stem Cell Rev Rep. 2024 Nov;20(8):2165-2193. doi: 10.1007/s12015-024-10791-7. Epub 2024 Sep 28.
2
Potential of Exosomes as Multifunctional Nanocarriers for Targeted Drug Delivery.外泌体作为多功能纳米载体用于靶向药物递送的潜力
Mol Biotechnol. 2024 Sep 13. doi: 10.1007/s12033-024-01268-6.
3
Engineered exosomes as drug and RNA co-delivery system: new hope for enhanced therapeutics?工程外泌体作为药物和RNA共递送系统:增强治疗效果的新希望?
Front Bioeng Biotechnol. 2023 Sep 26;11:1254356. doi: 10.3389/fbioe.2023.1254356. eCollection 2023.
4
Global trend in exosome isolation and application: an update concept in management of diseases.全球外泌体分离与应用趋势:疾病管理的新概念
Mol Cell Biochem. 2024 Mar;479(3):679-691. doi: 10.1007/s11010-023-04756-6. Epub 2023 May 11.
5
CAR-NKT cell therapy: a new promising paradigm of cancer immunotherapy.嵌合抗原受体自然杀伤T细胞疗法:癌症免疫疗法的一种新的有前景的模式。
Cancer Cell Int. 2023 May 8;23(1):86. doi: 10.1186/s12935-023-02923-9.
6
Recent advances in the roles of exosomal microRNAs (exomiRs) in hematologic neoplasms: pathogenesis, diagnosis, and treatment.外泌体 microRNAs(exomiRs)在血液系统恶性肿瘤中的作用的最新进展:发病机制、诊断和治疗。
Cell Commun Signal. 2023 May 1;21(1):88. doi: 10.1186/s12964-023-01102-7.
7
MicroRNA-125b as a valuable predictive marker for outcome after autologous hematopoietic stem cell transplantation.微小 RNA-125b 作为自体造血干细胞移植后预后的有价值的预测标志物。
BMC Cancer. 2023 Mar 3;23(1):202. doi: 10.1186/s12885-023-10665-0.
8
Exosomes as smart drug delivery vehicles for cancer immunotherapy.外泌体作为癌症免疫治疗的智能药物递送载体。
Front Immunol. 2023 Jan 17;13:1093607. doi: 10.3389/fimmu.2022.1093607. eCollection 2022.
9
Exosome-Based Smart Drug Delivery Tool for Cancer Theranostics.基于外泌体的智能药物递送工具用于癌症治疗诊断。
ACS Biomater Sci Eng. 2023 Feb 13;9(2):577-594. doi: 10.1021/acsbiomaterials.2c01329. Epub 2023 Jan 9.
10
Exosome engineering in cell therapy and drug delivery.细胞治疗和药物递送中的外泌体工程。
Inflammopharmacology. 2023 Feb;31(1):145-169. doi: 10.1007/s10787-022-01115-7. Epub 2023 Jan 7.